Buy Tirzepatide in Israel
Tirzepatide is a dual GIP and GLP-1 receptor agonist. SURMOUNT-1 demonstrated 20.9% mean body weight reduction at 72 weeks — the largest weight reduction in any Phase 3 obesity trial at time of publication. QSC ships to Israel from the EU regional warehouse in 5–8 business days. Israel spends approximately 5% of GDP on R&D — the world's highest ratio — with the Weizmann Institute, Technion, Hebrew University, TAU, and BGU all maintaining active research programmes in GIP/GLP-1 Dual Agonist and related fields.
Tirzepatide (CAS 2023788-19-2): Tirzepatide (CAS 2023788-19-2) is a 39-amino acid peptide activating both GIPR and GLP-1R. Dual agonism produces additive insulin secretion, enhanced beta-cell function, and greater hypothalamic appetite suppression compared to GLP-1 monotherapy. Half-life approximately 5 days supports weekly dosing. QSC supplies research-grade Tirzepatide at >=99% HPLC purity, Janoshik COA. Order at qscpeptide.com.
Buy Tirzepatide — EU Warehouse to Israel
₪230 / USD 62 · 5–8 business days nationwide. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.
Buy Tirzepatide at QSC →Israel Shipping Details
| Destination | Delivery Time |
|---|---|
| Tel Aviv / Gush Dan / Rehovot | 5–8 business days |
| Jerusalem / Modi'in / Beit Shemesh | 6–9 business days |
| Haifa / Technion corridor | 6–9 business days |
| Beersheba / South District | 6–10 business days |
| North District (Galilee, Golan) | 6–10 business days |
| Tracking number | All orders |
| Shipping cost | Free |
| Purity | >=99% HPLC |
| COA | Janoshik (independent) |
| Payment | Bitcoin / USDT |
| Pricing | ILS (₪) and USD listed |
Mechanism of Action
Tirzepatide (CAS 2023788-19-2) is a 39-amino acid peptide activating both GIPR and GLP-1R. Dual agonism produces additive insulin secretion, enhanced beta-cell function, and greater hypothalamic appetite suppression compared to GLP-1 monotherapy. Half-life approximately 5 days supports weekly dosing.
Tirzepatide — Research Data
SURMOUNT-1 (NCT04184622): 20.9% weight reduction at 72 weeks (highest dose). SURPASS-2 vs semaglutide: superior outcomes on both HbA1c and weight. TAU Sackler Faculty of Medicine and Hebrew University's Diabetes Research Centre have active dual incretin research programmes.
Available Nationwide
QSC ships Tirzepatide from the EU regional warehouse to all Israeli cities: Tel Aviv and Gush Dan, Rehovot (Weizmann Institute), Jerusalem (Hebrew University, Hadassah), Haifa (Technion, Rambam), Beersheba (BGU), and all northern, southern and central districts. Israel's world-class research institutions — Weizmann, Technion, HUJI, TAU, BGU, Bar-Ilan — all within the delivery window. ILS (₪) and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.